LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

Home・Stock List・Becton Dickinson and Co

Becton Dickinson and Co

Open

Sector Healthcare

238.7 1.07

Buy Sell

Overview

Share price change

24h

Current

Min

235.95

Max

241.32

Key metrics
By Trading Economics
Income	255M 537M
Sales	344M 5.1B
P/E Sector Avg	56.75 79.786
EPS	3.17
Profit margin	10.634
Employees	73,000
EBITDA	215M 1.3B

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+17.97 upside

Dividends
By Dow Jones
Next Earnings	1 Aug 2024
Next Dividend date	30 Sept 2024
Next Ex Dividend date	9 Sept 2024

Market Stats
By TradingEconomics
Market Cap	-390M 66B
Previous open	237.63
Previous close	238.7

News Sentiment

By Acuity

19%

81%

35 / 369 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

230.34 / N/A Support & Resistance

Becton Dickinson and Co Chart

Related News

3 Jun 2024, 11:18 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash

2 May 2024, 11:07 UTC

Earnings

Becton Dickinson Shakes Up 2024 Outlook After Growing 2Q Sales, Earnings

1 Feb 2024, 12:04 UTC

Earnings

Becton Dickinson Lifts 2024 Outlook After Sales Rise in 1Q

4 Jun 2024, 17:26 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3 Jun 2024, 15:30 UTC

Hot Stocks

Stocks to Watch Monday: GameStop, AMC, Paramount, Nvidia -- WSJ

3 Jun 2024, 13:26 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3 Jun 2024, 12:25 UTC

Peer Comparison

Price change

Becton Dickinson and Co Forecast

Price Target

By TipRanks

17.97% upside

12 Months Forecast

Average 280 USD 17.97%

High 312 USD

Low 255 USD

Based on 10 Wall Street analysts offering 12 month price targets forBecton Dickinson and Co - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to Becton Dickinson and Co - Dist in the past 3 months.

Technical Score

By Trading Central

230.34 / N/ASupport & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There are no events.

Sentiment

By Acuity

35 / 369 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Becton Dickinson and Co

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.